162 related articles for article (PubMed ID: 31088661)
21. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
[TBL] [Abstract][Full Text] [Related]
22. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
[TBL] [Abstract][Full Text] [Related]
23. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
Costacou T; Saenger AK; Orchard TJ
Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
[TBL] [Abstract][Full Text] [Related]
24. Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
Berry JD; Chen H; Nambi V; Ambrosius WT; Ascher SB; Shlipak MG; Ix JH; Gupta R; Killeen A; Toto RD; Kitzman DW; Ballantyne CM; de Lemos JA
Circulation; 2023 Jan; 147(4):310-323. PubMed ID: 36533535
[TBL] [Abstract][Full Text] [Related]
25. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
[TBL] [Abstract][Full Text] [Related]
26. Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study.
Mathews L; Ishigami J; Ding N; Hoogeveen RC; Kucharska-Newton A; Ballantyne CM; Gottesman R; Selvin E; Matsushita K
J Am Heart Assoc; 2020 Mar; 9(5):e013560. PubMed ID: 32114886
[TBL] [Abstract][Full Text] [Related]
27. High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study.
Matsushita K; Kwak L; Yang C; Pang Y; Ballew SH; Sang Y; Hoogeveen RC; Jaar BG; Selvin E; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Coresh J; Hirsch AT
Eur Heart J; 2018 Jul; 39(25):2412-2419. PubMed ID: 29579246
[TBL] [Abstract][Full Text] [Related]
28. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial.
Gaggin HK; Dang PV; Do LD; deFilippi CR; Christenson RH; Lewandrowski EL; Lewandrowski KB; Truong BQ; Pham VQ; Vu VH; Vu TV; Nguyen TB; Belcher AM; Femia A; Kelley C; Januzzi JL
Clin Chem; 2014 May; 60(5):758-64. PubMed ID: 24568795
[TBL] [Abstract][Full Text] [Related]
29. Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.
Jia Y; Li D; Yu J; Liu Y; Li F; Li W; Zhang Q; Gao Y; Zhang W; Zeng Z; Zeng R; Liao X; Zhao Q; Wan Z
BMC Geriatr; 2022 Apr; 22(1):321. PubMed ID: 35413794
[TBL] [Abstract][Full Text] [Related]
30. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
[TBL] [Abstract][Full Text] [Related]
31. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
32. Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide.
Altintas S; Cardinaels EP; Versteylen MO; Joosen IA; Seifert M; Wildberger JE; Crijns HJ; Nelemans PJ; Van Dieijen-Visser MP; Mingels AM; Das M; Kietselaer BL
J Cardiovasc Comput Tomogr; 2016; 10(1):82-8. PubMed ID: 26481512
[TBL] [Abstract][Full Text] [Related]
33. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
[TBL] [Abstract][Full Text] [Related]
34. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.
Nambi V; Liu X; Chambless LE; de Lemos JA; Virani SS; Agarwal S; Boerwinkle E; Hoogeveen RC; Aguilar D; Astor BC; Srinivas PR; Deswal A; Mosley TH; Coresh J; Folsom AR; Heiss G; Ballantyne CM
Clin Chem; 2013 Dec; 59(12):1802-10. PubMed ID: 24036936
[TBL] [Abstract][Full Text] [Related]
35. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events.
Gyanwali B; Lai MKP; Lui B; Liew OW; Venketasubramanian N; Richards AM; Chen C; Hilal S
Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742
[TBL] [Abstract][Full Text] [Related]
36. Correlations of arterial stiffness/central hemodynamics with serum cardiac troponin T and natriuretic peptide levels in a middle-aged male worksite cohort.
Kimura K; Tomiyama H; Matsumoto C; Odaira M; Shiina K; Nagata M; Yamashina A
J Cardiol; 2015 Aug; 66(2):135-42. PubMed ID: 25467920
[TBL] [Abstract][Full Text] [Related]
37. Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study.
Lazo M; Chen Y; McEvoy JW; Ndumele C; Konety S; Ballantyne CM; Sharrett AR; Selvin E
Clin Chem; 2016 Sep; 62(9):1202-10. PubMed ID: 27440513
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
[TBL] [Abstract][Full Text] [Related]
39. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
[TBL] [Abstract][Full Text] [Related]
40. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
